Rain Therapeutics Inc. (RAIN) Tops Q3 EPS by 9c

Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q3 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Six Flags names Mark Pauls as chief operating officer
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform